Mumbai: Sun Pharmaceutical Industries said on 12 June that it has allotted 11.39 lakh shares upon conversion of 18,470 Foreign Currency Convertible Bonds (FCCBs).
The committee of directors in its meeting has recently allotted 11,39,901 equity shares of Rs 5 each at a premium of Rs724.30 per share upon conversion of 18,470 FCCBs of 1,000 dollar each, Sun Pharmaceutical said in a communique to the Bombay Stock Exchange (BSE).
Consequently, the paid-up equity share capital of the company has increased from 19,49,37,315 equity shares of Rs 5 each to 19,60,77,216 shares of the same value.
The shares of the company were last trading at Rs 1,066.50, up by 0.62% on the BSE.
“The products purchased will be delivered at the customer’s place and will be installed by expert technicians,” the provider of security and life-support solutions said in a communique to the Bombay Stock Exchange (BSE).
The shares of the company were last trading at 2.2% up at Rs 230 on the BSE.